SAMSUNG BIOLOGICS CO., LTD. AMENDMENT NO 1 TO PRODUCT SPECIFIC AGREEMENT CLINICAL PRODUCT DRUG SUBSTANCE
Source:SEC EDGAR database•Date:February 27, 2023•SIC:2834•CIK:2834
First Amendment to Product Agreement
Source:SEC EDGAR database•Date:August 4, 2016•SIC:2834•CIK:2834
LICENSE AND SUPPLY AGREEMENT
Source:SEC EDGAR database•Date:May 10, 2023•SIC:2834•CIK:2834
AMENDMENT NO. 4 TOLICENSE AGREEMENT
Source:SEC EDGAR database•Date:February 28, 2023•SIC:2834•CIK:2834
CONFIDENTIAL TREATMENT REQUESTED LICENSE AGREEMENT
Source:SEC EDGAR database•Date:February 5, 2018•SIC:2834•CIK:2834
EXCLUSIVE LICENSE AGREEMENT
Source:SEC EDGAR database•Date:March 7, 2023•SIC:2834•CIK:2834
NON-EXCLUSIVE LICENSE AGREEMENT
Source:SEC EDGAR database•Date:March 27, 2023•SIC:2836•CIK:2836
MASTER SERVICES AGREEMENT
Source:SEC EDGAR database•Date:May 8, 2023•SIC:2834•CIK:2834
(the Agreement)
Source:SEC EDGAR database•Date:February 13, 2018•SIC:2834•CIK:2834
ORAGENICS INC (OGEN) (CIK 0001174940)
Source:SEC EDGAR database•Date:November 15, 2021•SIC:2834•CIK:2834